A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants
PHASE1
This study compares LY900014, a drug that lowers blood sugar, with insulin ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
A Study of a New LY900014 Formulation in Healthy Participants
PHASE1
This study evaluates a new formulation of LY900014, a drug that lowers bloo...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants
PHASE1
This study evaluates a new formulation of insulin lispro, LY900014, a drug ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
A Study to Compare 2 Formulations of LY900014 in Healthy Participants
PHASE1
The study involves a comparison of a LY900014 U-200 formulation with a LY90...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants
PHASE1
The aims of this study are to evaluate:
* The safety and tolerability of a...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus
PHASE1
The purpose of this study is to compare LY900014 with insulin lispro (Humal...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.